Source: BioPortfolio

Hera BioLabs: Hera BioLabs Hera and Demeetra Ag Bio Demeetra announce joint launch of CasCLOVER the clean alternative to CRISPRCas9 for drug discovery and bioprocessing

The companies are offering CasCLOVER in distinct fields of use Demeetra is operating in the pharmaceuticalindustrial bioprocessing space as well as agricultural biotechnology while Hera is focused on products tools and services for research and drug discov...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Michael Schlosser's photo - CEO of Hera BioLabs

CEO

Michael Schlosser

CEO Approval Rating

90/100